Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Form 8.3 - TAKEDA PHARMACEUTICAL CO LTD

21st Dec 2018 11:44

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser: Barclays PLC.
(b) Owner or controller of interest and short
positions disclosed, if different from 1(a):
(c) Name of offeror/offeree in relation to whose TAKEDA PHARMACEUTICAL CO LTD
relevant securities this form relates:
(d) If an exempt fund manager connected with an
offeror/offeree, state this and specify identity of
offeror/offeree:
(e) Date position held/dealing undertaken: 20 December 2018
(f) In addition to the company in 1(c) above, is the discloser making YES:
disclosures in respect of any other party to the offer? SHIRE PLC

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: Ordinary NPV
Interests Short Positions
Number (%) Number (%)
(1) Relevant securities owned
and/or controlled: 11,854,958 1.49% 15,628,354 1.97%
(2) Cash-settled derivatives:
15,679,753 1.97% 11,640,841 1.46%
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell: 10,514,600 1.32% 10,514,600 1.32%
TOTAL: 38,049,311 4.79% 37,783,795 4.75%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant Purchase/sale Number of Price per unit
security securities
ADR Purchase 5,000 16.8000 USD
ADR Purchase 16,800 16.7213 USD
ADR Purchase 125,510 16.7540 USD
ADR Purchase 363,945 16.7515 USD
ADR Sale 1,027 16.7500 USD
ADR Sale 2,500 16.8000 USD
ADR Sale 16,800 16.7213 USD
ADR Sale 489,455 16.7521 USD
Ordinary NPV Purchase 100 3,832.0000 JPY
Ordinary NPV Purchase 100 3,893.0000 JPY
Ordinary NPV Purchase 500 3,786.0000 JPY
Ordinary NPV Purchase 2,200 3,907.1363 JPY
Ordinary NPV Purchase 3,700 3,803.3314 JPY
Ordinary NPV Purchase 4,000 3,840.0000 JPY
Ordinary NPV Purchase 4,100 3,819.9024 JPY
Ordinary NPV Purchase 4,100 3,830.1707 JPY
Ordinary NPV Purchase 4,300 3,684.5348 JPY
Ordinary NPV Purchase 4,500 3,839.3333 JPY
Ordinary NPV Purchase 4,700 3,639.0425 JPY
Ordinary NPV Purchase 5,300 3,910.8113 JPY
Ordinary NPV Purchase 5,900 3,829.3525 JPY
Ordinary NPV Purchase 8,300 3,809.2650 JPY
Ordinary NPV Purchase 9,200 3,837.7500 JPY
Ordinary NPV Purchase 10,500 3,829.7619 JPY
Ordinary NPV Purchase 13,300 3,812.7218 JPY
Ordinary NPV Purchase 14,000 3,734.2857 JPY
Ordinary NPV Purchase 16,600 3,761.1385 JPY
Ordinary NPV Purchase 19,600 3,756.2653 JPY
Ordinary NPV Purchase 23,300 3,838.8656 JPY
Ordinary NPV Purchase 23,800 3,641.9033 JPY
Ordinary NPV Purchase 24,900 3,817.2590 JPY
Ordinary NPV Purchase 30,000 3,839.8186 JPY
Ordinary NPV Purchase 30,700 3,813.4299 JPY
Ordinary NPV Purchase 34,400 3,842.6133 JPY
Ordinary NPV Purchase 41,600 3,695.1851 JPY
Ordinary NPV Purchase 55,300 3,833.0605 JPY
Ordinary NPV Purchase 63,000 3,830.4380 JPY
Ordinary NPV Purchase 63,500 3,794.7488 JPY
Ordinary NPV Purchase 73,300 3,821.8697 JPY
Ordinary NPV Purchase 78,600 3,852.0114 JPY
Ordinary NPV Purchase 93,800 3,809.7249 JPY
Ordinary NPV Purchase 150,000 3,857.2533 JPY
Ordinary NPV Purchase 445,500 3,811.0936 JPY
Ordinary NPV Purchase 934,100 3,808.7174 JPY
Ordinary NPV Purchase 2,254,200 3,812.7546 JPY
Ordinary NPV Purchase 2,324,000 3,811.6574 JPY
Ordinary NPV Sale 18 3,908.3333 JPY
Ordinary NPV Sale 100 3,840.8000 JPY
Ordinary NPV Sale 100 3,799.0000 JPY
Ordinary NPV Sale 200 3,789.5000 JPY
Ordinary NPV Sale 200 3,789.7000 JPY
Ordinary NPV Sale 500 3,786.0000 JPY
Ordinary NPV Sale 682 3,805.0777 JPY
Ordinary NPV Sale 768 3,725.2943 JPY
Ordinary NPV Sale 1,000 3,847.1000 JPY
Ordinary NPV Sale 1,580 3,749.0727 JPY
Ordinary NPV Sale 1,600 3,799.1875 JPY
Ordinary NPV Sale 1,640 3,765.0037 JPY
Ordinary NPV Sale 1,954 3,832.9560 JPY
Ordinary NPV Sale 2,100 3,785.0000 JPY
Ordinary NPV Sale 2,300 3,815.8695 JPY
Ordinary NPV Sale 4,100 3,830.1707 JPY
Ordinary NPV Sale 4,239 3,788.4671 JPY
Ordinary NPV Sale 4,400 3,877.0000 JPY
Ordinary NPV Sale 4,860 3,843.2820 JPY
Ordinary NPV Sale 5,987 3,764.3345 JPY
Ordinary NPV Sale 6,000 3,829.5133 JPY
Ordinary NPV Sale 6,200 3,837.5000 JPY
Ordinary NPV Sale 6,830 3,849.0386 JPY
Ordinary NPV Sale 8,000 3,836.9375 JPY
Ordinary NPV Sale 12,808 3,728.0943 JPY
Ordinary NPV Sale 13,800 3,730.4855 JPY
Ordinary NPV Sale 14,500 3,805.0790 JPY
Ordinary NPV Sale 19,200 3,838.7130 JPY
Ordinary NPV Sale 23,300 3,838.6931 JPY
Ordinary NPV Sale 23,318 3,802.6969 JPY
Ordinary NPV Sale 25,100 3,817.6474 JPY
Ordinary NPV Sale 27,100 3,828.2527 JPY
Ordinary NPV Sale 29,700 3,820.1750 JPY
Ordinary NPV Sale 30,000 3,839.8186 JPY
Ordinary NPV Sale 63,500 3,794.7488 JPY
Ordinary NPV Sale 73,300 3,821.8697 JPY
Ordinary NPV Sale 75,000 3,839.4520 JPY
Ordinary NPV Sale 93,800 3,809.7249 JPY
Ordinary NPV Sale 137,100 3,833.7359 JPY
Ordinary NPV Sale 153,700 3,827.9785 JPY
Ordinary NPV Sale 176,900 3,794.7518 JPY
Ordinary NPV Sale 445,500 3,810.3241 JPY
Ordinary NPV Sale 1,026,400 3,814.9545 JPY
Ordinary NPV Sale 2,207,300 3,813.7038 JPY
Ordinary NPV Sale 2,259,600 3,812.9854 JPY

(b) Cash-settled derivative transactions

Class of Product Nature of dealing Number of Price per
relevant description reference unit
security securities
Ordinary NPV SWAP Long 18 3,908.3263 JPY
Ordinary NPV SWAP Long 60 3,818.1181 JPY
Ordinary NPV SWAP Long 111 3,865.6134 JPY
Ordinary NPV SWAP Long 121 3,820.6179 JPY
Ordinary NPV SWAP Long 159 3,868.3096 JPY
Ordinary NPV SWAP Long 211 3,774.0159 JPY
Ordinary NPV SWAP Long 242 3,811.3688 JPY
Ordinary NPV SWAP Long 336 3,856.2927 JPY
Ordinary NPV SWAP Long 360 3,804.6195 JPY
Ordinary NPV SWAP Long 502 3,865.7234 JPY
Ordinary NPV SWAP Long 616 3,867.2889 JPY
Ordinary NPV SWAP Long 745 3,814.1524 JPY
Ordinary NPV SWAP Long 768 3,725.2941 JPY
Ordinary NPV SWAP Long 1,183 3,733.3870 JPY
Ordinary NPV SWAP Long 1,207 3,820.1546 JPY
Ordinary NPV SWAP Long 1,293 3,815.8874 JPY
Ordinary NPV SWAP Long 1,344 3,865.2166 JPY
Ordinary NPV SWAP Long 1,428 3,823.2254 JPY
Ordinary NPV SWAP Long 1,580 3,749.0726 JPY
Ordinary NPV SWAP Long 2,054 3,834.0174 JPY
Ordinary NPV SWAP Long 2,300 3,801.5000 JPY
Ordinary NPV SWAP Long 2,687 3,862.0177 JPY
Ordinary NPV SWAP Long 2,772 3,819.4699 JPY
Ordinary NPV SWAP Long 2,835 3,751.4546 JPY
Ordinary NPV SWAP Long 4,164 3,732.9234 JPY
Ordinary NPV SWAP Long 4,534 3,857.8544 JPY
Ordinary NPV SWAP Long 5,400 3,801.5437 JPY
Ordinary NPV SWAP Long 5,570 3,859.4794 JPY
Ordinary NPV SWAP Long 9,100 3,807.1767 JPY
Ordinary NPV SWAP Long 12,808 3,728.0942 JPY
Ordinary NPV SWAP Long 14,976 3,778.4733 JPY
Ordinary NPV SWAP Short 200 3,798.5000 JPY
Ordinary NPV SWAP Short 2,300 3,801.5000 JPY
Ordinary NPV SWAP Short 3,700 3,803.3314 JPY
Ordinary NPV SWAP Short 27,600 3,841.6727 JPY

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit

(ii) Exercise

Class of relevant security Product description

e.g. call option

Exercising/ exercised against Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 21 Dec 2018
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

143221.01

SUPPLEMENTAL FORM 8 (OPEN POSITIONS)

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.

Note 5(i) on Rule 8 of the Takeover Code (the “Code”)

1. KEY INFORMATION

Identity of the person whose positions/dealings Barclays PLC.
are being disclosed:
Name of offeror/offeree in relation to whose TAKEDA PHARMACEUTICAL CO LTD
relevant securities this from relates:

2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

Class Product Writing, Number Exercise Type Expiry
of description purchasing, of price date
relevant selling, securities per unit
security varying etc to which
option
relates
Ordinary NPV Call Options Purchased 150,000 3889.0000 American 11 Jun 2021
Ordinary NPV Call Options Written -114,000 4750.0200 European 14 May 2019
Ordinary NPV Call Options Written -104,700 5065.8300 European 17 Apr 2019
Ordinary NPV Call Options Written -75,900 4286.5200 European 6 Sep 2019
Ordinary NPV Call Options Written -70,000 4598.0000 European 14 Jun 2019
Ordinary NPV Put Options Purchased -150,000 3889.0000 American 11 Jun 2021
Ordinary NPV Put Options Written 70,000 4598.0000 European 14 Jun 2019
Ordinary NPV Put Options Written 75,900 4286.5200 European 6 Sep 2019
Ordinary NPV Put Options Written 104,700 5065.8300 European 17 Apr 2019
Ordinary NPV Put Options Written 114,000 4750.0200 European 14 May 2019
Ordinary NPV Call Options Purchased 10,000,000 4206.0397 European 7 Jan 2019
Ordinary NPV Call Options Written -10,000,000 4206.0397 European 7 Jan 2019
Ordinary NPV Put Options Purchased -10,000,000 4206.0397 European 7 Jan 2019
Ordinary NPV Put Options Written 10,000,000 4206.0397 European 7 Jan 2019

3. AGREEMENTS TO PURCHASE OR SELL ETC.

Full details should be given so that the nature of the interest or position can be fully understood:

It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.

The currency of all prices and other monetary amounts should be stated.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20181221005195/en/

Copyright Business Wire 2018


Related Shares:

Barclays
FTSE 100 Latest
Value8,758.99
Change0.95